In summary, these results demonstrated SNHG16 and PTBP1 are positively associated with 5-Fu resistance in gastric cancer, suggesting targeting SNHG16 and PTBP1 could contribute to enhancing the cytotoxicity of chemotherapeutic agents. The gene discussed is PTBP1; the disease is gastric cancer.